Fig. 1 · Structure
Documents & Downloads
3'-Hydroxy Repaglinide
Cat. No.
A70137
CAS
874908-14-2
Drug Metabolite
3'-Hydroxy Repaglinide is a primary metabolite of Repaglinide, primarily formed through CYP2C8 enzymatic activity. As a carbamoylmethyl benzoic acid (CMBA) derivative, it plays a significant role in the pharmacokinetics of Repaglinide, a drug used for the management of type II diabetes. This compound is essential for understanding the metabolism and efficacy of Repaglinide in clinical research and drug development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 874908-14-2 |
| Applications | Drug Metabolite |
| Formula | C27H36N2O5 |
| Molecular Weight | 468.59 |
| SMILES | O=C(O)C1=CC=C(CC(NC(C2=CC=CC=C2N3CC(O)CCC3)CC(C)C)=O)C=C1OCC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.